Certified Product

Alyval Bliss

Intimate cream. Special formula that helps repair and regenerate delicate tissues in the intimate area.

€24,00

30 ml

A cosmetic solution designed to support the restoration of the well-being of skin and mucous membranes affected by dysbiosis. Formulated with the patented pealiquitech™ and SynchroGyn Complex™ technologies, together with other targeted active ingredients, it:

Helps restore eubiosis by rebalancing the intimate microbiota and supporting the growth and persistence of Lactobacillus crispatus
Helps relieve discomfort such as itching, burning and irritation

For optimal results, use as part of the Confidence Ritual in combination with ALYVAL START for daily cleansing.

pealiquitech™ + SynchroGyn Complex™ HELP IMPROVE

Candidiasis

Cystitis

Bacterial Vaginosis

Vaginitis

Certified Product

FRAGRANCE
FREE

GYNECOLOGICALLY
TESTED

NATURAL
PRODUCTS

Helps restore eubiosis by rebalancing the intimate microbiota and supporting the growth and persistence of Lactobacillus crispatus
Helps relieve discomfort such as itching, burning and irritation

Apply a small amount of product (finger-tip) once a day/as needed directly to the affected area with a light massage. For external use only.

pealiquitech™

SynchroGyn Complex™

PHYTOCOSMETIC SYSTEM (Rhubarb, Great Burnet, Indian Chrysanthemum) – Supports the skin microbiome

The innovative pealiquitech™ technology uses a PEA solubilisation process that enables high-concentration cosmetic use in an active, bioavailable form. ALYVAL uses a proprietary patent based on pealiquitech™ technology for the use of PEA in topical formulations.

Helps support the natural balance of the intimate microbiota. The exclusive cosmetic complex developed to help restore and maintain the balance of the intimate microbiota, supporting protective lactobacilli and helping to counteract bacteria associated with dysbiosis.

in just 28 days:

-90% frequent intimate discomfort
-83% burning | -82% itching | -80% stinging
-100% discomfort during urination
-50% frequent vaginal discharge

The percentages shown refer to the change in the number of women (out of 20 participants) experiencing each symptom, comparing baseline values with those recorded after 28 days of use.